Earth Science Tech (ETST) Free Cash Flow (2011 - 2026)
Earth Science Tech (ETST) posted Free Cash Flow of $765431.0 for Q1 2026, up 547.31% on a QoQ basis from -$171118.0 in Q4 2025, and down 62.36% year-over-year from $2.0 million in Q1 2025.
Earth Science Tech (ETST) Free Cash Flow (2011 - 2026) Analysis & Trends
Earth Science Tech's Free Cash Flow history runs 15 years deep, the most recent figure standing at $765431.0 for Q1 2026.
- Quarterly Free Cash Flow fell 62.36% year-over-year to $765431.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 70.06% YoY) and the FY2026 annual result came in at $1.2 million, down 70.06% from the prior year.
- Free Cash Flow was $765431.0 for Q1 2026 at Earth Science Tech, up from -$171118.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at $2.0 million in Q1 2025 and bottomed at -$351660.0 in Q3 2022.
- A 5-year average of $306167.9 and a median of $151995.0 in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 2391.24% — and 2024, when it jumped 1697.53%.
- Earth Science Tech's Free Cash Flow stood at -$293517.0 in 2022, then jumped by 161.11% to $179370.0 in 2023, then declined by 15.26% to $151995.0 in 2024, then tumbled by 212.58% to -$171118.0 in 2025, then jumped by 547.31% to $765431.0 in 2026.
- Business Quant data shows ETST's Free Cash Flow at $765431.0 in Q1 2026, -$171118.0 in Q4 2025, and $661820.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn | 765,431.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 765,431.00 |
| Mar 31, 2026 | 765,431.00 |
| Dec 31, 2025 | -171,118.00 |
| Dec 31, 2025 | -171,118.00 |
| Sep 30, 2025 | 661,820.00 |
| Sep 30, 2025 | 661,820.00 |
| Jun 30, 2025 | -71,889.00 |
| Jun 30, 2025 | -71,889.00 |
| Mar 31, 2025 | 2.03 Mn |
| Mar 31, 2025 | 2.03 Mn |
| Dec 31, 2024 | 151,995.00 |
| Dec 31, 2024 | 151,995.00 |
| Sep 30, 2024 | 910,362.00 |
| Sep 30, 2024 | 910,362.00 |
| Jun 30, 2024 | 858,960.00 |
| Jun 30, 2024 | 858,960.00 |
| Mar 31, 2024 | 898,961.00 |
| Mar 31, 2024 | 898,961.00 |
| Dec 31, 2023 | 179,370.00 |
| Dec 31, 2023 | 179,370.00 |